Mintz, Levin, Cohn, Ferris, Glovsky and Popeo advised BeiGene on the deal. BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160) announced its option, collaboration, and license agreement with pharmaceutical...
BeiGene’s Collaboration and License agreement with Novartis
BeiGene’s $3.5 Billion Listing in Shanghai
Fangda Partners advised BeiGene, while Davis Polk advised the representatives of the several underwriters on the deal. BeiGene executed a US$3.5 billion initial public offering and listing...